02556nam 2200553Ia 450 991078030400332120230607214358.092-4-068069-1(CKB)111087028329462(EBL)284606(OCoLC)476034703(SSID)ssj0000173793(PQKBManifestationID)11176938(PQKBTitleCode)TC0000173793(PQKBWorkID)10185451(PQKB)11300191(MiAaPQ)EBC284606(Au-PeEL)EBL284606(CaPaEBR)ebr10062381(EXLCZ)9911108702832946220020404d2001 uf 0engur|n|---|||||txtccrHow to develop and implement a national drug policy[electronic resource]2nd ed.Geneva World Health Organizationc20011 online resource (96 p.)Updates and replaces Guidelines for developing national drug policies, 1988.0-585-47315-3 92-4-154547-X Includes bibliographical references.Contents; Contributors; Abbreviations and acronyms; Preface; 1. Introduction; 2. The national drug policy process; 3. Legislation; 4. Selection of essential drugs; 5. Affordability; 6. Drug financing; 7. Supply systems; 8. Drug regulation; 9. Rational use of drugs; 10. Research; 11. Human resources development; 12. Monitoring and evaluation; ReferencesIn Europe today, HIV/AIDS prevention, treatment and care are needed more than ever. HIV incidence steady in western and central Europe, and dramatically increasing in eastern Europe remains a major challenge to public health in the 21st century. With more than two million people living with HIV/AIDS in the WHO European Region, no country has been spared. This book tells the story of HIV/AIDS in Europe from a broad variety of perspectives: biomedical, social, cultural, economic and political. The authors are leading experts from across the Region and include both the infected and the affected,Pharmaceutical policyDrug utilizationPharmaceutical policy.Drug utilization.362.1/782World Health OrganizationMiAaPQMiAaPQMiAaPQBOOK9910780304003321How to develop and implement a national drug policy3671516UNINA